BRIACELL THERAPEUTICS CORP. Shares Outstanding (Cover Page)
BRIACELL THERAPEUTICS CORP. (BCTX) had Shares Outstanding (Cover Page) of 8.70 million shares as of 2026-06-09, per its 10-Q filed 2026-06-09.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-06-09
- 2026-06-09: Entity Common Stock, Shares Outstanding 8.70M shares.
- 2026-03-10: Entity Common Stock, Shares Outstanding 7.25M shares.
- 2025-12-11: Entity Common Stock, Shares Outstanding 1.88M shares.
- 2025-10-15: Entity Common Stock, Shares Outstanding 1.88M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-06-09 | 8.70M shares 10-Q · filed 2026-06-09 |
| 2026-03-10 | 7.25M shares 10-Q · filed 2026-03-10 |
| 2025-12-11 | 1.88M shares 10-Q · filed 2025-12-11 |
| 2025-10-15 | 1.88M shares 10-K · filed 2025-10-16 |
| 2025-06-16 | 6.78M shares 10-Q · filed 2025-06-16 |
| 2025-03-12 | 3.71M shares 10-Q · filed 2025-03-12 |
| 2024-12-16 | 44.20M shares 10-Q · filed 2024-12-16 |
| 2024-10-28 | 36.18M shares 10-K · filed 2024-10-29 |
| 2024-06-14 | 18.28M shares 10-Q · filed 2024-06-14 |
| 2024-03-18 | 15.98M shares 10-Q · filed 2024-03-18 |
| 2023-12-14 | 15.98M shares 10-Q · filed 2023-12-14 |
| 2023-10-25 | 15.98M shares 10-K · filed 2023-10-25 |
| 2023-06-14 | 15.98M shares 10-Q · filed 2023-06-14 |
| 2023-03-15 | 15.52M shares 10-Q · filed 2023-03-16 |
| 2022-12-14 | 15.52M shares 10-Q · filed 2022-12-14 |
| 2022-10-27 | 15.52M shares 10-K · filed 2022-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |